Mirada Medical UK
Mirada Medical UK
6 Projects, page 1 of 2
assignment_turned_in Project2019 - 2028Partners:UCL, The Rosalind Franklin Institute, Eli Lilly and Company Limited, Biogen, Digital Surgery +94 partnersUCL,The Rosalind Franklin Institute,Eli Lilly and Company Limited,Biogen,Digital Surgery,IXICO Ltd,Philips Healthcare (Global),Multiple Sclerosis (MS) Society UK,Elekta UK Ltd,Elekta UK Ltd,JPK Instruments Limited,Brain Products GmbH,SU,Creatv MicroTech (United States),Alzheimer's Society,Scintacor Ltd,Alzheimer's Research UK,Visulytix Ltd,Stanford University Medical School,Shimadzu Corporation,Fujifilm Visualsonics Inc,X-Tek Systems Ltd,UCL Hospitals NHS Foundation Trust,Visulytix Ltd,Precision Acoustics (United Kingdom),icometrix,Mediso,MS,Alzheimer's Society,Moorfields Eye Hosp NHS Foundation Trust,GE Healthcare,QMENTA Imaging SL,Bruker UK Ltd,Digital Surgery,Direct Conversion GmbH,Intuitive Surgical Inc,Gold Standard Phantoms,Fujifilm Visualsonics Inc,Scintacor Ltd,SIEMENS PLC,SmartTarget Ltd,Indigo Scientific Ltd,Creatv MicroTech,Eli Lilly and Company Limited,Philips Healthcare,Direct Conversion GmbH,Mirada Medical UK,Stanford Synchroton Radiation Laboratory,GSK,COSMONiO Ltd,Alzheimer's Research UK,SmartTarget Ltd,QMENTA Imaging SL,Max Planck Institutes,GE Healthcare,Cystic Fibrosis Research Trust,Moorfields Eye NHS Foundation Trust,Max-Planck-Gymnasium,CYSTIC FIBROSIS TRUST,Great Ormond Street Hospital Children's Charity,Cystic Fibrosis Trust,Vision RT Ltd,Rigaku,Nikon Metrology UK Ltd,GlaxoSmithKline PLC,COSMONiO Ltd,Precision Acoustics Ltd,MR Solutions Limited,GlaxoSmithKline (Harlow),Philips (Netherlands),icoMetrix,Great Ormond Street Hospital,RCaH,Intuitive Surgical Inc,NPL,Siemens PLC,MR Solutions Limited,Bruker UK Ltd,Nikon Metrology UK Ltd,GE Aviation,Perceive3D,Motor Neurone Disease Association,Mediso,Agility Design Solutions,Shimadzu Corp.,National Physical Laboratory NPL,Indigo Scientific Ltd,Mirada Medical UK,Perceive3D,Motor Neurone Disease Association,University College London Hospital (UCLH) NHS Foundation Trust,IXICO Technologies Ltd,Brain Products GmbH,Research Complex at Harwell,Gold Standard Phantoms,Rigaku,Vision RT Ltd,Biogen,The Rosalind Franklin InstituteFunder: UK Research and Innovation Project Code: EP/S021930/1Funder Contribution: 6,386,980 GBPWe propose to create the EPSRC Centre for Doctoral Training (CDT) in intelligent integrated imaging in healthcare (i4health) at University College London (UCL). Our aim is to nurture the UK's future leaders in next-generation medical imaging research, development and enterprise, equipping them to produce future disruptive healthcare innovations either focused on or including imaging. Building on the success of our current CDT in Medical Imaging, the new CDT will focus on an exciting new vision: to unlock the full potential of medical imaging by harnessing new associated transformative technologies enabling us to consider medical imaging as a component within integrated healthcare systems. We retain a focus on medical imaging technology - from basic imaging technologies (devices and hardware, imaging physics, acquisition and reconstruction), through image computing (image analysis and computational modeling), to integrated image-based systems (diagnostic and interventional systems) - topics we have developed world-leading capability and expertise on over the last decade. Beyond this, the new initiative in i4health is to capitalise on UCL's unique combination of strengths in four complementary areas: 1) machine learning and AI; 2) data science and health informatics; 3) robotics and sensing; 4) human-computer interaction (HCI). Furthermore, we frame this research training and development in a range of clinical areas including areas in which UCL is internationally leading, as well as areas where we have up-and-coming capability that the i4health CDT can help bring to fruition: cancer imaging, cardiovascular imaging, imaging infection and inflammation, neuroimaging, ophthalmology imaging, pediatric and perinatal imaging. This unique combination of engineering and clinical skills and context will provide trainees with the essential capabilities for realizing future image-based technologies. That will rely on joint modelling of imaging and non-imaging data to integrate diverse sources of information, understanding of hardware the produces or uses images, consideration of user interaction with image-based information, and a deep understanding of clinical and biomedical aims and requirements, as well as an ability to consider research and development from the perspective of responsible innovation. Building on our proven track record, we will attract the very best aspiring young minds, equipping them with essential training in imaging and computational sciences as well as clinical context and entrepreneurship. We will provide a world-class research environment and mentorship producing a critical mass of future scientists and engineers poised to develop and translate cutting-edge engineering solutions to the most pressing healthcare challenges.
more_vert assignment_turned_in Project2015 - 2020Partners:British Broadcasting Corporation - BBC, MirriAd, BBC Television Centre/Wood Lane, Skolkovo Inst of Sci and Tech (Skoltech), Microsoft Research Ltd +24 partnersBritish Broadcasting Corporation - BBC,MirriAd,BBC Television Centre/Wood Lane,Skolkovo Inst of Sci and Tech (Skoltech),Microsoft Research Ltd,Qualcomm Technologies, Inc.,Intelligent Ultrasound,Wellcome Trust Sanger Institute,Qualcomm Incorporated,GRS,BP British Petroleum,The Wellcome Trust Sanger Institute,Max Planck Institutes,Oxford Uni. Hosps. NHS Foundation Trust,Mirada Medical UK,Oxford University Hospitals NHS Trust,General Electric,MICROSOFT RESEARCH LIMITED,Oxford University Hospitals NHS Trust,BBC,Max-Planck-Gymnasium,Yotta Ltd,MirriAd,University of Oxford,BP (International),Yotta Ltd,GE Global Research,Intelligent Ultrasound,Mirada Medical UKFunder: UK Research and Innovation Project Code: EP/M013774/1Funder Contribution: 4,467,650 GBPThe Programme is organised into two themes. Research theme one will develop new computer vision algorithms to enable efficient search and description of vast image and video datasets - for example of the entire video archive of the BBC. Our vision is that anything visual should be searchable for, in the manner of a Google search of the web: by specifying a query, and having results returned immediately, irrespective of the size of the data. Such enabling capabilities will have widespread application both for general image/video search - consider how Google's web search has opened up new areas - and also for designing customized solutions for searching. A second aspect of theme 1 is to automatically extract detailed descriptions of the visual content. The aim here is to achieve human like performance and beyond, for example in recognizing configurations of parts and spatial layout, counting and delineating objects, or recognizing human actions and inter-actions in videos, significantly superseding the current limitations of computer vision systems, and enabling new and far reaching applications. The new algorithms will learn automatically, building on recent breakthroughs in large scale discriminative and deep machine learning. They will be capable of weakly-supervised learning, for example from images and videos downloaded from the internet, and require very little human supervision. The second theme addresses transfer and translation. This also has two aspects. The first is to apply the new computer vision methodologies to `non-natural' sensors and devices, such as ultrasound imaging and X-ray, which have different characteristics (noise, dimension, invariances) to the standard RGB channels of data captured by `natural' cameras (iphones, TV cameras). The second aspect of this theme is to seek impact in a variety of other disciplines and industry which today greatly under-utilise the power of the latest computer vision ideas. We will target these disciplines to enable them to leapfrog the divide between what they use (or do not use) today which is dominated by manual review and highly interactive analysis frame-by-frame, to a new era where automated efficient sorting, detection and mensuration of very large datasets becomes the norm. In short, our goal is to ensure that the newly developed methods are used by academic researchers in other areas, and turned into products for societal and economic benefit. To this end open source software, datasets, and demonstrators will be disseminated on the project website. The ubiquity of digital imaging means that every UK citizen may potentially benefit from the Programme research in different ways. One example is an enhanced iplayer that can search for where particular characters appear in a programme, or intelligently fast forward to the next `hugging' sequence. A second is wider deployment of lower cost imaging solutions in healthcare delivery. A third, also motivated by healthcare, is through the employment of new machine learning methods for validating targets for drug discovery based on microscopy images
more_vert assignment_turned_in Project2019 - 2028Partners:Nagoya University, Memorial Sloan- Kettering Cancer Centre, NIHR Imperial Biomedical Research Centre, Xtronics Ltd., University of Copenhagen +80 partnersNagoya University,Memorial Sloan- Kettering Cancer Centre,NIHR Imperial Biomedical Research Centre,Xtronics Ltd.,University of Copenhagen,NVIDIA Limited (UK),King's College Hospital Charitable Trust,Image Analysis Group,Optellum Ltd,TheraPanacea,Medicines Discovery Catapault,SU,Siemens AG,NIHR Imperial Biomedical Research Centre,Astrazeneca,PHILIPS MEDICAL SYSTEMS NEDERLAND BV,GE Healthcare,Image Analysis Ltd (UK),icometrix,Medicines Discovery Catapult,Radiologics,Brigham and Women's Hospital,Stanford Synchroton Radiation Laboratory,UNIL,Brainminer,Massachusetts Institute of Technology,Theragnostics Ltd,NVIDIA Limited,QUIBIM,MR Code BV,GE Healthcare,Biotronics 3D Ltd,Graduiertenkolleg BIOQIC,NIHR Imperial Biomedical Research Centre,HKU,GSTT NIHR Biomedical Research Centre,AstraZeneca plc,Mirada Medical UK,GSK,Medicines Discovery Catapult,Brigham and Women's Hospital,Stanford University,Therapanacea,Ultromics Ltd,Lightpoint Medical Ltd,quibim,German Cancer Research Center,Perspectum Diagnostics,GE Aviation,Memorial Sloan- Kettering Cancer Centre,German Cancer Research Centre,Lightpoint Medical Ltd,GlaxoSmithKline PLC,Massachusetts General Hospital East,ASTRAZENECA UK LIMITED,University of Copenhagen,Siemens Healthineers,icoMetrix,South London and Maudsley NHS Trust,MIT,Massachusetts Institute of Technology,Biotronics 3D Ltd,GlaxoSmithKline (Harlow),Philips (Netherlands),PHILIPS MEDICAL SYSTEMS NEDERLAND,HeartFlow Inc.,HeartFlow Inc.,Graduiertenkolleg BIOQIC,Optellum Ltd,MR Code BV,Imanova Limited,Radiologics Inc,National Institute for Health Research,IMANOVA LIMITED,GSTT NIHR Biomedical Research Centre,Perspectum Diagnostics,Brainminer,King's College Hospital NHS Foundn Trust,Xtronics Ltd.,KCL,Mirada Medical UK,Theragnostics Ltd,Massachusetts General Hospital East,Ultromics Ltd,AKHFunder: UK Research and Innovation Project Code: EP/S022104/1Funder Contribution: 6,339,630 GBPMedical imaging has made major contributions to healthcare, by providing noninvasive diagnostics, guidance, and unparalleled monitoring of treatment and understanding of disease. A suite of multimodal imaging modalities is nowadays available, and scanner hardware technology continues to advance, with high-field, hybrid, real-time and hand-held imaging further pushing on technological boundaries; furthermore, new developments of contrast agents and radioactive tracers open exciting new avenues in designing more targeted molecular imaging probes. Conventionally, the individual imaging components of probes and contrast mechanisms, acquisition and reconstruction, and analysis and interpretation are addressed separately. This however, is creating unnecessary silos between otherwise highly synergistic disciplines, which our current EPSRC CDT in Medical Imaging at King's College London and Imperial College London has already started to successfully challenge. Our new CDT will push this even further by bridging the different imaging disciplines and clinical applications, with the interdisciplinary research based on complementary collaborations and new research directions that would not have been possible five years ago. Through a comprehensive, integrated training programme in Smart Medical Imaging we will train the next generation of medical imaging researchers that is needed to reach the full potential of medical imaging through so-called "smart" imaging technologies. To achieve this ambitious goal we have developed four new Scientific Themes which are synergistically interlinked: AI-enabled Imaging, Smart Imaging Probes, Emerging Imaging and Affordable Imaging. This is complemented by a dedicated 1+3 training programme, with a new MRes in Healthcare Technologies at King's as the foundation year, strong industry links in form of industry placements, careers mentoring and workshops, entrepreneurship training, and opportunities in engaging with international training programmes and academic labs to become part of a wider cohort. Cohort building, Responsible Research & Innovation, Equality, Diversity & Inclusion, and Public Engagement will be firmly embedded in this programme. Students graduating from this CDT will have acquired a broad set of scientific and transferable skills that will enable them to work across the different medical imaging sub-disciplines, gaining a high employability over wider sectors.
more_vert assignment_turned_in Project2014 - 2025Partners:Carl Zeiss SMT Ltd, Software Sustainability Institute, GlaxoSmithKline, Carl Zeiss Ltd, Nottingham Uni Hospitals NHS Trust +26 partnersCarl Zeiss SMT Ltd,Software Sustainability Institute,GlaxoSmithKline,Carl Zeiss Ltd,Nottingham Uni Hospitals NHS Trust,GlaxoSmithKline plc (remove),GE (General Electric Company) UK,Siemens plc (UK),P1vital,Nottingham Uni Hospitals NHS Trust,SIEMENS PLC,Northern Powergrid (United Kingdom),Philips Healthcare (Global),p1vital,F.Hoffman-La Roche (replace?),Philips Healthcare,Oxford Uni. Hosps. NHS Foundation Trust,Mirada Medical UK,Oxford University Hospitals NHS Trust,Oxford University Hospitals NHS Trust,Roche (Switzerland),GlaxoSmithKline (Harlow),Philips (Netherlands),Image Solutions (UK) Ltd,The Brilliant Club,University of Oxford,IMAGE SOLUTIONS (UK) LIMITED,Software Sustainability Institute,The Brilliant Club,GE Aviation,Mirada Medical UKFunder: UK Research and Innovation Project Code: EP/L016052/1Funder Contribution: 3,899,940 GBPThe United Kingdom has a strong history of having developed imaging techniques and technologies that allow us to visualize a range of biomedical phenomena, from being able to visualise molecules inside individual cells, to being able to take pictures non invasively inside patients. Examples of this include the pioneering work done by Sir Godfrey Hounsfield (Nobel Prize winner and co-inventor of the Computed Tomography scanner), and Sir Peter Mansfield of Nottingham University (Nobel Prize winner and co-inventor of magnetic resonance imaging). A recent report from two of the UK Research Councils showed that the UK still has a world-leading research profile in this area, but also showed that there was a shortage of trained UK individuals who are experts in medical imaging. This means that our research institutions and industries struggle to employ suitably qualified individuals, and either have to employ non-UK nationals or cannot undertake the work they wish to. The aim of this Centre for Doctoral Training is therefore to address the need for more trained imaging scientists by linking together two of the UK's top research-intensive universities to deliver a rigorous training programme in this area. In particular, and in response to the needs expressed both by our industry colleagues and by our NHS colleagues, we will put in place a doctoral training programme that gives students an understanding of the full landscape of medical imaging (e.g. different types of imaging, different scales of imaging from cellular imaging up to whole human imaging, and different ways of analyzing the resulting images). Since these will mostly be students with a background in the physical sciences (physics, engineering and mathematics) we will also provide them with a training in the basic biology of cells, and in the range of diseases in which medical imaging can make a difference. Following a first year of training the students will work in specialist research laboratories in Oxford and Nottingham (with some students working between the two institutions). Both universities have world-renowned scientists and excellent facilities to host research projects for the students, culminating in each student receiving a doctoral degree from either Nottingham or Oxford. The range of research and opportunities available to these students is very large, with researchers in both institutions working at all scales of medical imaging (single cells to whole humans), and on various diseases, including cancer, brain disorders, and heart disorders. As major partners we will work with colleagues from industry so that our students gain experience in working in an industry environment, and so that some of the projects they work on are ones that are proposed by industry. This partnership will also help us produce trained experts who have an appreciation for the way that industry operates, and an understanding of how research ideas can be commercialized so that they become a source of income to the nation. We believe that by having a rigorous doctoral training programme like this we will ensure that the UK is well placed to compete academically and industrially in the future. We also believe that there will be benefits to the NHS, since our graduates will develop imaging techniques that will refine the way the NHS treats us, thus saving money and making the treatments that we receive more relevant to us as individuals.
more_vert assignment_turned_in Project2015 - 2021Partners:DHSC, Mirada Medical UK, Dudley Group of Hospitals NHS Trust, Carl Zeiss SMT Ltd, Public Health England +35 partnersDHSC,Mirada Medical UK,Dudley Group of Hospitals NHS Trust,Carl Zeiss SMT Ltd,Public Health England,Liverpool Women's Hospital,Bionow Ltd,Carl Zeiss Ltd,AstraZeneca (Global),Liverpool Women's Hospital,Durham University,University of Liverpool,Astra Pharmaceuticals Canada,University of Edinburgh,Liverpool Heart and Chest Hosp NHS Trust,Liverpool Health Partners,Unilever (United Kingdom),PUBLIC HEALTH ENGLAND,Bionow Ltd,North West Coast Academic Health Sci Nwk,University of Salford,Clatterbridge Cen for Oncology NHS Trust,Liverpool Uni Hospitals NHS Fdn Trust,Liverpool Maternity Hospital,Liverpool Health Partners,University of Liverpool,University of Liverpool,PHE,Dudley Group of Hospitals NHS Trust,Clatterbridge Cancer Ctr NHS Fdn Trust,Walton Centre NHS Foundation Trust,University of Salford,Unilever Corporate Research,Royal Liverpool and Broadgreen University Hospital NHS Trust,Mirada Medical UK,UNILEVER U.K. CENTRAL RESOURCES LIMITED,Walton Centre Neurology/Neurosurgery,Walton Centre Neurology/Neurosurgery,Liverpool Heart and Chest Hospital,Durham UniversityFunder: UK Research and Innovation Project Code: EP/N014499/1Funder Contribution: 2,004,300 GBPAs quality of life constantly improves, the average lifespan will continue to increase. Underlining this improvement is the vast amount of the UK government's support to NHS (£133.5 billion in year 2011/12) and the UK pharmaceutical industry's R&D large investment (4.9 billion to R&D in year 2011/12). The expectation of quality healthcare is inevitably high from all stakeholders. Fortunately recent advances in science and technology have enabled us to work towards personalised medicine and preventative care. This approach calls for a collective effort of researchers from a vast spectrum of specialised subjects. Advances in science and engineering is often accompanied by major development of mathematical sciences, as the latter underpin all other sciences. The UoL Centre will consist of a large and multidisciplinary team of applied and pure mathematicians, and statisticians together with healthcare researchers, clinicians and industrialists, collaborating with 15 HEIs and 40 NHS trusts plus other industrial partners and including our strongest groups: MRC Centre in Drug Safety Science, Centre for Cell imaging (CCI for live 3D and 4D imaging), Centre for Mathematical Imaging Techniques (unique in UK), Liverpool Biomedical EM unit, MRC Regenerative Medicine Hub, NIHR Health Protection Research Units, MRC Hub for Trials Methodology Research. Several research themes are highlighted below: Firstly, an improved understanding of the interaction dynamics of cells and tissues is crucial to developing effective future cures for cancer. Much of the current work is in 2D, with restrictive assumptions and without access to real data for modelling. We shall use the unparalleled real data of cell interactions in a 3D setting, generated at UoL's CCI. The real-life images obtained will have low contrast and noise and they will be analysed and enhanced by our imaging team through developing accurate and high resolution imaging models. The main imaging tools needed are segmentation methods (identifying objects such as cells and tissues regions in terms of sizes, shapes and precise boundaries). We shall propose and study a class of new 3D models, using our imaging data and analysis tools, to investigate and predict the spatial-temporal dynamics. Secondly, better models of how drugs are delivered to cells in tissues will improve personalised predictions of drug toxicity. We shall combine novel-imaging data of drug penetration into 3D experimental model systems with multi-scale mathematical models which scale-up from the level of cells to these model systems, with the ultimate aim of making better in-vitro to in-vivo predictions. Thirdly, there exist many competing models and software for imaging processing. However, for real images that have noise and are of low contrast, few methods are robust and accurate. To improve the modelling, applied and pure mathematicians team up to consider using more sophisticated tools of hyperbolic geometry and Riemann surfaces and fractional calculus to meet the demand for accuracy, and, applied mathematicians and statisticians will team up to design better data fidelity terms to model image discrepancies. Fourthly, resistance to current antibiotics means that previously treatable diseases are becoming deadly again. To understand and mitigate this, a better understanding is needed for how this resistance builds up across the human interaction networks and how it depends on antibiotic prescribing practices. To understand these scenarios, the mathematics competition in heterogeneous environments needs to be better understood. Our team links mathematical experts in analysing dynamical systems with experts in antimicrobial resistance and GPs to determine strategies that will mitigate or slow the development of anti-microbial resistance. Our research themes are aligned with, and will add value to, existing and current UoL and Research Council strategic investments, activities and future plans.
more_vert
chevron_left - 1
- 2
chevron_right
